Your browser doesn't support javascript.
loading
Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance).
Li, Megan; Mulkey, Flora; Jiang, Chen; O'Neil, Bert H; Schneider, Bryan P; Shen, Fei; Friedman, Paula N; Momozawa, Yukihide; Kubo, Michiaki; Niedzwiecki, Donna; Hochster, Howard S; Lenz, Heinz-Josef; Atkins, James N; Rugo, Hope S; Halabi, Susan; Kelly, William Kevin; McLeod, Howard L; Innocenti, Federico; Ratain, Mark J; Venook, Alan P; Owzar, Kouros; Kroetz, Deanna L.
Afiliação
  • Li M; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.
  • Mulkey F; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Jiang C; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • O'Neil BH; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Schneider BP; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Shen F; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
  • Friedman PN; Department of Medicine, University of Chicago Comprehensive Cancer, Chicago, Illinois.
  • Momozawa Y; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
  • Kubo M; Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
  • Niedzwiecki D; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Hochster HS; Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut.
  • Lenz HJ; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.
  • Atkins JN; Southeast Clinical Oncology Research Consortium, Winston-Salem, North Carolina.
  • Rugo HS; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Halabi S; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Kelly WK; Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • McLeod HL; DeBartolo Family Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida.
  • Innocenti F; Center for Pharmacogenomics and Individualized Therapy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Ratain MJ; Department of Medicine, University of Chicago Comprehensive Cancer, Chicago, Illinois.
  • Venook AP; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Owzar K; Alliance Statistics and Data Center, Duke University, Durham, North Carolina.
  • Kroetz DL; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.
Clin Cancer Res ; 24(19): 4734-4744, 2018 10 01.
Article em En | MEDLINE | ID: mdl-29871907
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Choque Térmico HSP90 / Transportador Equilibrativo 1 de Nucleosídeo / Hipertensão / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Choque Térmico HSP90 / Transportador Equilibrativo 1 de Nucleosídeo / Hipertensão / Neoplasias Idioma: En Ano de publicação: 2018 Tipo de documento: Article